82 related articles for article (PubMed ID: 22783696)
1. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival.
Meterissian SH; Skibber JM; Giacco GG; el-Naggar AK; Hess KR; Rich TA
Surgery; 1997 May; 121(5):479-87. PubMed ID: 9142144
[TBL] [Abstract][Full Text] [Related]
2. Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.
Cabanillas F; Nieves-Plaza M; Quevedo G; Echenique IA
P R Health Sci J; 2012 Jun; 31(2):52-8. PubMed ID: 22783696
[TBL] [Abstract][Full Text] [Related]
3. Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
Margalit O; Mamtani R; Kopetz S; Yang YX; Lawrence YR; Abu-Gazala S; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Oncologist; 2019 Aug; 24(8):e671-e676. PubMed ID: 30696723
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
5. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients.
Tarantino I; Warschkow R; Worni M; Merati-Kashani K; Köberle D; Schmied BM; Müller SA; Steffen T; Cerny T; Güller U
Br J Cancer; 2012 Jul; 107(2):266-74. PubMed ID: 22735902
[TBL] [Abstract][Full Text] [Related]
6. Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases.
Sharp L; McDevitt J; Brown C; Carsin AE; Comber H
Cancer; 2017 Jul; 123(13):2543-2550. PubMed ID: 28297071
[TBL] [Abstract][Full Text] [Related]
7. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
8. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
Wiig JN; Larsen SG; Dueland S; Giercksky KE
Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
[TBL] [Abstract][Full Text] [Related]
9. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
[TBL] [Abstract][Full Text] [Related]
10. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
Gérard JP; Conroy T; Bonnetain F; Bouché O; Chapet O; Closon-Dejardin MT; Untereiner M; Leduc B; Francois E; Maurel J; Seitz JF; Buecher B; Mackiewicz R; Ducreux M; Bedenne L
J Clin Oncol; 2006 Oct; 24(28):4620-5. PubMed ID: 17008704
[TBL] [Abstract][Full Text] [Related]
11. Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas.
Boonpipattanapong T; Chewatanakornkul S
J Clin Gastroenterol; 2006 Aug; 40(7):592-5. PubMed ID: 16917399
[TBL] [Abstract][Full Text] [Related]
12. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography.
Stipa F; Chessin DB; Shia J; Paty PB; Weiser M; Temple LK; Minsky BD; Wong WD; Guillem JG
Ann Surg Oncol; 2006 Aug; 13(8):1047-53. PubMed ID: 16865595
[TBL] [Abstract][Full Text] [Related]
13. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
Calvo FA; Serrano FJ; Diaz-González JA; Gomez-Espi M; Lozano E; Garcia R; de la Mata D; Arranz JA; García-Alfonso P; Pérez-Manga G; Alvarez E
Ann Oncol; 2006 Jul; 17(7):1103-10. PubMed ID: 16670204
[TBL] [Abstract][Full Text] [Related]
14. The influence of the surgeon's and the hospital's caseload on survival and local recurrence after colorectal cancer surgery.
Renzulli P; Lowy A; Maibach R; Egeli RA; Metzger U; Laffer UT
Surgery; 2006 Mar; 139(3):296-304. PubMed ID: 16546492
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]